Cleo Diagnostics (ASX:COV) Total Stockholders Equity : A$10.54 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Total Stockholders Equity?

Cleo Diagnostics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$10.54 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Cleo Diagnostics's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.08. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Cleo Diagnostics's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.00.

Cleo Diagnostics Total Stockholders Equity Historical Data

The historical data trend for Cleo Diagnostics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Total Stockholders Equity Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Total Stockholders Equity

-0.94

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
Total Stockholders Equity	-0.33	-0.94	10.54

Cleo Diagnostics (ASX:COV) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Cleo Diagnostics's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(10.54	-	0)	/	128.5
	=	0.08

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Cleo Diagnostics's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	10.54
	=	0.00

Cleo Diagnostics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines